Search Results 751-760 of 18216 for Immunode

1. A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy - Mayo Clinic

   Known Human Immunodeficiency Virus (HIV), active Hepatitis B Virus (HBV), and/or active Hepatitis C Virus (HCV) infection. Prior therapy with lenalidomide ...

2. Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Known to be human immunodeficiency virus (HIV) seropositive; Known active hepatitis A, B, or C infection; or known to be positive for hepatitis C virus (HCV) ...

3. A Study to Evaluate the Addition of Immunotherapy into Adjuvant Therapy for Non-small Cell Lung Cancer - Mayo Clinic

   Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this ...

4. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) - Mayo Clinic

   Subjects may be tested for human immunodeficiency virus (HIV) prior to ... immunodeficiency syndrome-defining opportunistic infection within the past ...

5. A Study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with Stage 3 Type 1 Diabetes - Mayo Clinic

   At screening, participant has positive serology for human immunodeficiency virus (HIV), hepatitis B (HBV), or hepatitis C (HCV). Participant has evidence of ...

6. SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction - Mayo Clinic

   Known active human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis C virus (HCV) infection. Inactive hepatitis carrier status or low ...

7. Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients with Relapsed or Relapsed/Refractory Multiple Myeloma - Mayo Clinic

   Ongoing or active systemic infection, active hepatitis B or C virus infection, or known human immunodeficiency virus (HIV) positive; Any serious medical or ...

8. Phase ll Study of Pirfenidone in Patients With RAILD - Mayo Clinic

   Medical history including Human Immunodeficiency Virus (HIV);; Medical history of viral hepatitis (positive Hep A antibody in the absence of elevated liver ...

9. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

   Are infected with human immunodeficiency virus (HIV);; QuantiFERON®-TB test or Purified Protein Derivative (PPD) skin test, or both, according to local ...

10. A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination with Crizotinib - Mayo Clinic

    Known history of human immunodeficiency virus (HIV) or seropositive test for hepatitis C virus or hepatitis B virus. Participating Mayo Clinic locations.